KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Assets Average: 2019-2024

Historic Assets Average for Esperion Therapeutics (ESPR) over the last 6 years, with Dec 2024 value amounting to $274.8 million.

  • Esperion Therapeutics' Assets Average rose 6.70% to $355.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $355.6 million, marking a year-over-year increase of 6.70%. This contributed to the annual value of $274.8 million for FY2024, which is 21.13% up from last year.
  • Latest data reveals that Esperion Therapeutics reported Assets Average of $274.8 million as of FY2024, which was up 21.13% from $226.9 million recorded in FY2023.
  • Esperion Therapeutics' Assets Average's 5-year high stood at $367.4 million during FY2021, with a 5-year trough of $226.9 million in FY2023.
  • Moreover, its 3-year median value for Assets Average was $274.8 million (2024), whereas its average is $272.1 million.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 58.62% in 2020, then decreased by 27.92% in 2023.
  • Over the past 5 years, Esperion Therapeutics' Assets Average (Yearly) stood at $283.9 million in 2020, then grew by 29.44% to $367.4 million in 2021, then fell by 14.33% to $314.8 million in 2022, then dropped by 27.92% to $226.9 million in 2023, then grew by 21.13% to $274.8 million in 2024.